Stifel raised the firm’s price target on Rocket Lab (RKLB) to $75 from $65 and keeps a Buy rating on the shares. Rocket Lab reported Q3 results that were better than expected for revenue and gross margin, while the Q4 outlook sees further top-line acceleration and improved margins, the analyst tells investors. With management targeting to have Neutron at the pad in Q1 of 2026, the firm sees this as “a more realistic goal, prioritizing mission success over speed,” the analyst added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RKLB:
- Rocket Lab USA: Strong Performance Amidst Neutron Delay and Financial Uncertainties
- Rocket Lab price target raised to $75 from $60 at Roth Capital
- Closing Bell Movers: CoreWeave down over 5% on lower sales, higher capex view
- Rocket Lab Reports Record Q3 2025 Revenue Growth
- RKLB Earnings: Rocket Lab Stock Surges after Strong Q3